Search Results 271-280 of 2256 for ☎어코드주소 [원탑보증.com/가입코드 111] 올인구조대 ☎

  1. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...

  2. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  3. Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS - Mayo Clinic

    Other important efficacy measures include time to respiratory events, clinical global impression (CGI), assessment of dyspnea using the Borg scale and sleep ...

  4. Patient Stories - Ajit H. Goenka, M.D. - Mayo Clinic

    Search for a doctor. Ajit H. Goenka, M.D.. Nuclear Medicine Specialist; Radiologist. Request an Appointment · Overview · Publications. Patient Stories.

  5. Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch - Mayo Clinic

    About this study. The goal of this clinical trial is to learn if mirikizumab works to treat pouch disorders in adults. The main questions it aims to answer ...

  6. Abhishek A. Mangaonkar, M.B.B.S. - Mayo Clinic Faculty Profiles

    Abhishek A. Mangaonkar, M.B.B.S., studies the immune microenvironment of myeloid cancers and bone marrow failure syndromes.

  7. A Study of the Relationship of Markers of Cellular Senescence to Skeletal Parameters in Type 2 Diabetes Mellitus - Mayo Clinic

    About this study. The purpose of this study is to test whether markers of cellular aging and the SASP are elevated in subjects with obesity and further ...

  8. Nilotinib and Combination Chemotherapy in Treating Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia - Mayo Clinic

    About this study. In this study researchers want to find out more about the side effects of a new drug for Philadelphia chromosome-positive (Ph+) acute ...

  9. A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders - Mayo Clinic

    A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders.

  10. Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery - Mayo Clinic

    About this study. RATIONALE: Sorafenib tosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth by blocking blood ...